Appointment booking for Dr. Abdulaziz Alomran, MD is currently not available.Dr. Abdulaziz Alomran, MD has not yet fully activated their profile on SelectWow.
Dr. Abdulaziz Alomran, MD (he/him) is a Dermatologist in Boston, MA with over 7 years of experience. What is your opinion of Dr. Abdulaziz Alomran, MD? Rate this provider below so other people can make informed decision.
Gender
Male (Approximately 36% of Dermatologists in Boston, MA are Male)
Education
Graduated in 2015
Degree Type
MD (Approximately 88% of Dermatologists in Boston, MA have MD degree)
Medical Specialties
Dermatologist (There are 301 Dermatologists available in Boston, MA, which is 48 times the average number of Dermatologists in similar U.S. locations)
Experience
7+ Years of Experience (About 45% less years of experience compared to the average Dermatologist in Boston, MA)
Approximately 55% of Dermatologists in Boston, MA have available research publications
Nodular lymphangitis related to methicillin-resistant staphylococcus aureus infection.
Nicole Trepanowski, Abdulaziz Alomran, Meera Mahalingam, Mariko R Yasuda, Rebecca I Hartman
Dermatology online journal 2023-04-15
Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.
Rachel G Casseres, Lisa Prussick, Pedro Zancanaro, Brooke Rothstein, Deep Joshipura, Ami Saraiya, Yana Turkowski, Shiu Chung Au, Abdulaziz Alomran, Rana Abdat, Minawaer Abudu, Courtney Kachuk, Nicole Dumont, Alice B Gottlieb, David Rosmarin
Journal of the American Academy of Dermatology 2020-02-07
Improving health literacy and treatment understanding of hidradenitis suppurativa using group educational interventions.
Lisa Prussick, Sarah Tonelli, Alice B Gottlieb, Deep Joshipura, Abdulaziz Alomran, Pedro Zancanaro, R N Courtney Kachuk, Nicole Dumont, David Rosmarin
The Journal of dermatological treatment 2019-06-24
Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
L Prussick, B Rothstein, D Joshipura, A Saraiya, Y Turkowski, R Abdat, A Alomran, P Zancanaro, C Kachuk, N Dumont, A B Gottlieb, D Rosmarin
The British journal of dermatology 2019-05-12
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.
Deep Joshipura, Abdulaziz Alomran, Pedro Zancanaro, David Rosmarin
Journal of the American Academy of Dermatology 2018-02-10
Payments From Medical Companies
(These can include payments from pharmaceutical companies, medical device companies, and other companies.)
Dr. Abdulaziz Alomran, MD has received over $405 in payments from medical companies (99% less than the average Dermatologist in Boston, MA)
Over $405 in payments for Food and Beverage (70% less than the average Dermatologist in Boston, MA)
ABBVIE INC. - $31.30 payment for Food and Beverage on 08/29/2024
GENZYME CORPORATION - $92.39 payment for Food and Beverage on 03/25/2022
Janssen Scientific Affairs, LLC - $119.90 payment for Food and Beverage on 11/02/2021
KCI USA, Inc - $125.00 payment for Food and Beverage on 02/12/2019
Shire North American Group Inc - $17.01 payment for Food and Beverage on 11/02/2018
Pacira Pharmaceuticals Incorporated - $19.88 payment for Food and Beverage on 08/28/2018
Do you have any questions about plastic surgery, dermatology and cosmetic dentistry treatments? You can now post those questions in SelectWow Forum and have our experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of questions, all for FREE! Register today and join the conversation!
Get Directions
Call: (617) 636-5891
